Join Weimin Zhu, the RabMAb technology founder, for this introductory on-demand webinar.
Learn why RabMAb® technology:
- provides higher affinity and specificity compared to traditional antibodies
- often gives lower background signal compared to traditional antibodies
- provides diverse epitope recognition
- is ideal for studying mouse models
- is ideal for demanding applications like IHC on FFPE tissue
View the full webinar at http://bit.ly/RabMAbwebinar